Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Goodness Growth Holdings, Inc. GDNSF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
37/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$0.45
-0.5%

Goodness Growth Holdings, Inc. (GDNSF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.45. It has a SharesGrow Score of 37/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Analyst consensus target is GDNSF = $0 (-0.5% upside).

Financials: revenue is $268.8T, +90145026.5%/yr average growth. Net income is $53.3T (loss), growing at -63454336.3%/yr. Net profit margin is -19.8% (negative). Gross margin is 47.3% (+9.2 pp trend).

Balance sheet: total debt is $26.2T against $307.4T equity (Debt-to-Equity (D/E) ratio 0.09, conservative). Current ratio is 1.59 (strong liquidity). Debt-to-assets is 3.2%. Total assets: $817.2T.

Analyst outlook: 0 / 2 analysts rate GDNSF as buy (0%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 35/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 63/100 (Partial), Future 26/100 (Fail), Income 10/100 (Fail).

$0.45
▼ 0.49% Downside
Average Price Target
The 12-month price target for Goodness Growth Holdings, Inc. is $0.45.

GDNSF SharesGrow Score Overview

43/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 35/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 63/100
Gross margin is + market cap
FUTURE 26/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — GDNSF

✗
VALUE Fail
35/100
GDNSF trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
58/100
GDNSF: +90145026.5%/yr revenue is, -63454336.3%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
67/100
Balance sheet GDNSF: Debt-to-Equity (D/E) ratio 0.09 (conservative), Current ratio is 1.59 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
63/100
GDNSF: Gross margin is 47.3% (+9.2 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 63/100. ≥ 70 = Pass.
View details →
✗
FUTURE Fail
26/100
Analyst outlook: 0 / 2 analysts rate GDNSF as buy (0%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
GDNSF: Net profit margin is -19.8%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
Market Cap$61.05M
Beta (1Y)1.42
Share Statistics
EPS (TTM)-0.09
Shares Outstanding$734.74B
IPO Date2019-03-22
Employees385
CEOJoshua Nathaniel Rosen
Financial Highlights & Ratios
Revenue (TTM)$268.77T
Gross Profit$127.1T
EBITDA$-1.05T
Net Income$-53.32T
Operating Income$-1.05T
Total Cash$103.25T
Total Debt$26.19T
Net Debt$-76.04T
Total Assets$817.15T
Price / Earnings (P/E)-5
Price / Sales (P/S)0
Analyst Forecast
1Y Price Target$0.45
Target High$0.45
Target Low$0.45
Upside-0.5%
Rating ConsensusHold
Analysts Covering2
Buy 0% Hold 100% Sell 0%
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINCA38238W1032

Price Chart

Track all markets on TradingView
GDNSF
Goodness Growth Holdings, Inc. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic

People Also View

VRNOF
VRNOF
Verano Holdings Corp.
$1.30
+8.33%
 AAWH
AAWH
Ascend Wellness Holdings, Inc.
$0.44
-6.38%
 AYRWF
AYRWF
Ayr Wellness Inc.
$0.01
+35.42%
 FFNTF
FFNTF
4Front Ventures Corp.
$0.00
+0.00%
 LOWLF
LOWLF
Lowell Farms Inc.
$0.00
+0.00%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message